Stephen Doster

  • Vanderbilt University

    ACS journal dedicates of 35-year anniversary issue to founding editor Larry Marnett

    In this issue of the 35th volume of Chemical Research in Toxicology (CRT), we share a special collection of science that celebrates the tremendous advances in this period at the intersection of chemistry and toxicology. Throughout the year, every issue of the Journal has borne a 35-year anniversary symbol to… Read More

    Oct. 18, 2022

  • Vanderbilt University

    Vanderbilt’s Monteggia and Rathmell elected to National Academy of Medicine

    Vanderbilt University faculty members have been elected this year to membership in the National Academy of Medicine, a prestigious, non-governmental organization that advises the nation and the world on important aspects of medical science, health care and public health. Monteggia was recruited to Vanderbilt in 2018 to… Read More

    Oct. 17, 2022

  • Vanderbilt University

    Gene tied to childhood epilepsy

    In the mammalian brain, the chief inhibitory neurotransmitter is called GABA. The gene SLC6A1 encodes the GABA transporter GAT1, and in Neurobiology of Disease, Felicia Mermer, Sarah Poliquin, Jing-Qiong Kang, MD, PhD, and colleagues report experiments — in silico, in vitro and in mice-o… Read More

    Oct. 13, 2022

  • Hinton et al receive grant to host underrepresented minorities in STEM conference

    Hinton et al receive grant to host underrepresented minorities in STEM conference

    The Quality Education for Minorities Network, in partnership with Vanderbilt University, Louisiana Tech University, North Dakota State University and Temple University researchers, has been awarded nearly $70,000 in funding from the National Science Foundation to host the Pipelines to Pathways: Humanizing Diversity in STEM Conference. The conference aims to engage… Read More

    Oct. 7, 2022

  • Dr. James Crowe Jr., professor of medicine, in his lab at Medical Research Building IV. Dr. Crowe is the subject of a feature article in the upcoming Winter 2018 issue of Vanderbilt Magazine. Crowe, who is the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology, as well as director of the Vanderbilt Vaccine Center, has spent his career hunting for a universal flu vaccine. He has re-engineered how flu vaccines work and is on the edge of creating a single shot that covers all flu strains. In a new initiative announced in October, he will lead an international team of researchers as they launch clinical trials of his new vaccine.(John Russell/Vanderbilt University)

    Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America

    James Crowe Jr., MD, director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization, for his team’s role in developing human monoclonal antibodies and vaccine candidates against COVID-19. The award, which was announced Oct. 6,… Read More

    Oct. 7, 2022

  • Vanderbilt University

    Skaar et al land grant to build top-line biosafety facility

    Vanderbilt University Medical Center has been awarded a nearly $8 million grant from the National Institutes of Health to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms. VUMC currently has two BSL3 labs, but they are small, outdated and… Read More

    Oct. 7, 2022

  • Vanderbilt University

    Colon cancer researchers awarded NCI grant for study of early lesions

    Vanderbilt University Medical Center has received a five-year, $5 million grant from the National Cancer Institute to study precancerous lesions and early cancers in the colon, with the goal of developing new ways to prevent colorectal cancer, the nation’s second leading cancer killer. Robert Coffey, MD, Martha Shrubsole, PhD, and Ken… Read More

    Sep. 29, 2022

  • Vanderbilt University

    Lee named 2022 Innovation Fund investigator by The Pew Charitable Trusts

    Dr. Ethan Lee, professor of cell and developmental biology and pharmacology, has been named a 2022 Innovation Fund investigator by The Pew Charitable Trusts. As a vote of confidence in the power of collaborative, interdisciplinary research, Pew created the Innovation Fund in 2017 to encourage partnerships among alumni of Pew’s  biomedical programs. Combining… Read More

    Sep. 28, 2022

  • The best of both worlds: Blending assays to understand human genome regulation

    The best of both worlds: Blending assays to understand human genome regulation

    Assistant Professor of Biochemistry Emily Hodges and graduate student Tyler Hansen used a blended approach to create a new, multi-omic method to identify and characterize gene regulatory elements—non-coding DNA sequences that control gene expression—in the human genome. The new technique, ATAC-STARR-seq, was published in Genome Research. During… Read More

    Sep. 20, 2022

  • Vanderbilt University

    Roden leads effort to map heart disease-causing genetic variations

    One in 100 people have genetic variations that can cause potentially life-threatening heart conditions, including high cholesterol (lipid disorders), heart muscle disease (cardiomyopathies), and abnormal heart rhythms (arrhythmias). Yet the functional impact of most of these cardiovascular genetic variants — whether they disrupt normal function or are harmless — is… Read More

    Sep. 15, 2022